» Articles » PMID: 24599752

Production, Purification and Titration of a Lentivirus-based Vector for Gene Delivery Purposes

Overview
Journal Cytotechnology
Specialties Biotechnology
Genetics
Date 2014 Mar 7
PMID 24599752
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Viral vectors are valuable tools to deliver genetic materials into cells. Vectors derived from human immunodeficiency virus type 1 are being widely used for gene delivery, mainly because they are able to transduce both dividing and non-dividing cells which leads to stable and long term gene expression. In addition, these types of vectors are safe, with low toxicity, high stability and cell type specificity. Therefore, this work was aimed to produce lentivirus-based vector using a three-plasmid system. To produce this system, the eGFP marker gene was cloned into the plasmid pWPXLd. Subsequently, this vector plasmid, along with packaging plasmids, psPAX2 and envelope plasmid, pMD2.G, was co-transfected into packaging cell line (293T) using calcium phosphate method. 48 h post transfection, the constructed viral vector was harvested, purified and concentrated and stored at -80 °C for next experiments. The titration of the vector was carried out, using ELISA, flowcytometry, and fluorescent microscopy. Finally, transduction of HEK-293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell lines was carried out with indicated cell numbers and multiplicities of infections of the vector in the presence of polybrene. Using this system, high titer lentivirus at titers of up to 2 × 10(8) transducing units/ml (TU/ml) was successfully generated and its transduction efficacy was improved by seven to over 20-fold in various cell types. We demonstrate the applicability of this vector for the efficient transduction of dividing and non-dividing cells, including HEK-293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell line. Transduction efficiency yielded titers of (6.3 ± 1.2) 10(5) TU/ml. Furthermore, lentivirus transferred transgene was expressed at high level in the target cells and expression was followed until 90 days after transduction. Thus, the vector generated in this work, might be able to deliver the transgene into a wide range of mammalian cells.

Citing Articles

Phosphoproteomic Profiling Reveals mTOR Signaling in Sustaining Macrophage Phagocytosis of Cancer Cells.

Wang B, Cao X, Garcia-Mansfield K, Zhou J, Manousopoulou A, Pirrotte P Cancers (Basel). 2025; 16(24.

PMID: 39766137 PMC: 11674635. DOI: 10.3390/cancers16244238.


ACE2-Decorated Virus-Like Particles Effectively Block SARS-CoV-2 Infection.

Bayraktar C, Kayabolen A, Odabas A, Durgun A, Kok I, Sevinc K Int J Nanomedicine. 2024; 19:6931-6943.

PMID: 39005960 PMC: 11246629. DOI: 10.2147/IJN.S446093.


Effects of an indole derivative on cell proliferation, transfection, and alternative splicing in production of lentiviral vectors by transient co-transfection.

Mier N, Roper D PLoS One. 2024; 19(6):e0297817.

PMID: 38833479 PMC: 11149887. DOI: 10.1371/journal.pone.0297817.


Detection of Hypoxia in 2D and 3D Cell Culture Systems Using Genetically Encoded Fluorescent Hypoxia Sensors.

Fleischhammer T, Dienemann S, Ulber N, Pepelanova I, Lavrentieva A Methods Mol Biol. 2024; 2755:31-48.

PMID: 38319567 DOI: 10.1007/978-1-0716-3633-6_2.


Engineering lentivirus envelope VSV-G for liver targeted delivery of IDOL-shRNA to ameliorate hypercholesterolemia and atherosclerosis.

Wang W, Chen X, Chen J, Xu M, Liu Y, Yang S Mol Ther Nucleic Acids. 2024; 35(1):102115.

PMID: 38314097 PMC: 10835450. DOI: 10.1016/j.omtn.2024.102115.


References
1.
Tiscornia G, Singer O, Verma I . Production and purification of lentiviral vectors. Nat Protoc. 2007; 1(1):241-5. DOI: 10.1038/nprot.2006.37. View

2.
Segura M, Garnier A, Durocher Y, Ansorge S, Kamen A . New protocol for lentiviral vector mass production. Methods Mol Biol. 2010; 614:39-52. DOI: 10.1007/978-1-60761-533-0_2. View

3.
Liao W, Ning G . Knockdown of apolipoprotein B, an atherogenic apolipoprotein, in HepG2 cells by lentivirus-mediated siRNA. Biochem Biophys Res Commun. 2006; 344(2):478-83. DOI: 10.1016/j.bbrc.2006.03.164. View

4.
Bartz S, Vodicka M . Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods. 1997; 12(4):337-42. DOI: 10.1006/meth.1997.0487. View

5.
Reiser J, Harmison G, Brady R, Karlsson S, Schubert M . Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A. 1996; 93(26):15266-71. PMC: 26392. DOI: 10.1073/pnas.93.26.15266. View